ARCHIVES

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

This article is from The Cancer Letter archive.

Vol. 25 No. 22 | June 4, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue”

September 14, 1984

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013

OMB Proposal Would Slash NIH Budget $500 Million, NCI’s Reduction Could Be As Much As $125 Million

January 3, 1986

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974